5.0
23. Okt. 2012
Aktueller Mitarbeiter, mehr als 5 Jahre
White Plains, NY
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
* Many strong employees that actually care about patient health * Solid upper management that has guided the company through many tough times * Lots of cash-- ready to acquire companies and compounds to build pipeline
Kontras
* Patent expiration of blockbusters provides uncertain future * Collaborative efforts with other pharma companies poses a risk * Conservative marketing approach allows more aggressive competitors to take advantage with bolder claims